Nucleic acid binding, RNA-binding
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 1 |
GO:0005849 | mRNA cleavage factor complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4HXP8
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006379 | mRNA cleavage | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 1 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 176 | 180 | PF00656 | 0.628 |
CLV_NRD_NRD_1 | 358 | 360 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 366 | 368 | PF00675 | 0.539 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.290 |
CLV_PCSK_KEX2_1 | 401 | 403 | PF00082 | 0.714 |
CLV_PCSK_PC1ET2_1 | 401 | 403 | PF00082 | 0.714 |
CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.464 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 398 | 402 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.235 |
CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.274 |
CLV_Separin_Metazoa | 356 | 360 | PF03568 | 0.502 |
DEG_APCC_DBOX_1 | 133 | 141 | PF00400 | 0.487 |
DEG_SCF_FBW7_1 | 1 | 8 | PF00400 | 0.652 |
DOC_MAPK_gen_1 | 76 | 82 | PF00069 | 0.474 |
DOC_MAPK_MEF2A_6 | 297 | 304 | PF00069 | 0.544 |
DOC_PP2B_LxvP_1 | 203 | 206 | PF13499 | 0.727 |
DOC_PP4_FxxP_1 | 334 | 337 | PF00568 | 0.724 |
DOC_PP4_MxPP_1 | 265 | 268 | PF00568 | 0.720 |
DOC_PP4_MxPP_1 | 286 | 289 | PF00568 | 0.713 |
DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.543 |
DOC_USP7_MATH_1 | 382 | 386 | PF00917 | 0.656 |
DOC_USP7_MATH_1 | 400 | 404 | PF00917 | 0.625 |
DOC_USP7_UBL2_3 | 345 | 349 | PF12436 | 0.604 |
DOC_USP7_UBL2_3 | 360 | 364 | PF12436 | 0.426 |
DOC_USP7_UBL2_3 | 368 | 372 | PF12436 | 0.546 |
DOC_USP7_UBL2_3 | 397 | 401 | PF12436 | 0.623 |
DOC_USP7_UBL2_3 | 405 | 409 | PF12436 | 0.616 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.672 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.624 |
DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.489 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.757 |
LIG_Actin_WH2_2 | 14 | 29 | PF00022 | 0.474 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.577 |
LIG_eIF4E_1 | 68 | 74 | PF01652 | 0.474 |
LIG_FHA_1 | 341 | 347 | PF00498 | 0.529 |
LIG_FHA_2 | 174 | 180 | PF00498 | 0.631 |
LIG_FHA_2 | 33 | 39 | PF00498 | 0.474 |
LIG_FHA_2 | 56 | 62 | PF00498 | 0.474 |
LIG_Integrin_isoDGR_2 | 42 | 44 | PF01839 | 0.274 |
LIG_LIR_Gen_1 | 352 | 362 | PF02991 | 0.504 |
LIG_LIR_Nem_3 | 352 | 358 | PF02991 | 0.506 |
LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.417 |
LIG_SH2_STAP1 | 365 | 369 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.474 |
LIG_SH3_1 | 297 | 303 | PF00018 | 0.641 |
LIG_SH3_3 | 265 | 271 | PF00018 | 0.649 |
LIG_SH3_3 | 297 | 303 | PF00018 | 0.581 |
LIG_SH3_3 | 84 | 90 | PF00018 | 0.535 |
LIG_TRAF2_2 | 273 | 278 | PF00917 | 0.675 |
LIG_UBA3_1 | 136 | 144 | PF00899 | 0.445 |
LIG_WW_3 | 266 | 270 | PF00397 | 0.647 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.641 |
MOD_CK1_1 | 385 | 391 | PF00069 | 0.627 |
MOD_CK2_1 | 400 | 406 | PF00069 | 0.603 |
MOD_Cter_Amidation | 74 | 77 | PF01082 | 0.274 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.608 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.539 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.654 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.723 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.536 |
MOD_GlcNHglycan | 259 | 262 | PF01048 | 0.685 |
MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.677 |
MOD_GlcNHglycan | 383 | 387 | PF01048 | 0.630 |
MOD_GlcNHglycan | 388 | 391 | PF01048 | 0.617 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.652 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.623 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.724 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.560 |
MOD_GSK3_1 | 382 | 389 | PF00069 | 0.735 |
MOD_GSK3_1 | 400 | 407 | PF00069 | 0.428 |
MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.658 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.537 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.492 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.711 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.546 |
MOD_NEK2_2 | 340 | 345 | PF00069 | 0.582 |
MOD_Plk_1 | 17 | 23 | PF00069 | 0.474 |
MOD_Plk_1 | 37 | 43 | PF00069 | 0.311 |
MOD_Plk_2-3 | 55 | 61 | PF00069 | 0.474 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.705 |
MOD_Plk_4 | 32 | 38 | PF00069 | 0.474 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.663 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.618 |
MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.482 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.756 |
MOD_SUMO_rev_2 | 361 | 369 | PF00179 | 0.513 |
MOD_SUMO_rev_2 | 389 | 399 | PF00179 | 0.623 |
TRG_DiLeu_BaEn_1 | 132 | 137 | PF01217 | 0.476 |
TRG_DiLeu_BaLyEn_6 | 131 | 136 | PF01217 | 0.477 |
TRG_ENDOCYTIC_2 | 263 | 266 | PF00928 | 0.650 |
TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.474 |
TRG_NLS_MonoExtC_3 | 400 | 405 | PF00514 | 0.623 |
TRG_NLS_MonoExtN_4 | 398 | 405 | PF00514 | 0.622 |
TRG_Pf-PMV_PEXEL_1 | 134 | 138 | PF00026 | 0.489 |
TRG_Pf-PMV_PEXEL_1 | 367 | 371 | PF00026 | 0.534 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P353 | Leptomonas seymouri | 54% | 100% |
A0A3Q8IE55 | Leishmania donovani | 100% | 100% |
E9AI57 | Leishmania braziliensis | 85% | 100% |
E9ARF9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4QE20 | Leishmania major | 95% | 100% |